Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 193 pages)

 

Export 38 results:
Author [ Title(Asc)] Type Year
Filters: Author is Card, T. R.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
A. J. Walker, West, J., Card, T. R., Crooks, C., Kirwan, C. C., and Grainge, M. J., “When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data”, Blood, vol. 127, pp. 849-57; quiz 953, 2016.
V
U. T. Khan, Walker, A. J., Baig, S., Card, T. R., Kirwan, C. C., and Grainge, M. J., “Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis”, BMC Cancer, vol. 17, p. 747, 2017.
A. J. Walker, West, J., Card, T. R., Humes, D. J., and Grainge, M. J., “Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England”, J Thromb Haemost, vol. 12, pp. 641-9, 2014.
U
C. J. Crooks, Card, T. R., and West, J., “The Use of a Bayesian Hierarchy to Develop and Validate a Co-Morbidity Score to Predict Mortality for Linked Primary and Secondary Care Data from the NHS in England”, PLoS One, vol. 11, p. e0165507, 2016.
S
A. J. Walker, Grainge, M., Bates, T. E., and Card, T. R., “Survival of glioma and colorectal cancer patients using tricyclic antidepressants post-diagnosis”, Cancer Causes Control, vol. 23, pp. 1959-64, 2012.
R
A. J. Walker, Baldwin, D. R., Card, T. R., Powell, H. A., Hubbard, R. B., and Grainge, M. J., “Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data”, Br J Cancer, vol. 115, pp. 115-21, 2016.
T. P. C. Chu, Grainge, M. J., and Card, T. R., “The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity”, Aliment Pharmacol Ther, vol. 48, pp. 1099-1108, 2018.
J. West, Logan, R. F., Card, T. R., Smith, C., and Hubbard, R., “Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study”, Aliment Pharmacol Ther, vol. 20, pp. 73-9, 2004.
J. West, Logan, R. F., Hubbard, R. B., and Card, T. R., “Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn's disease: a general population-based study”, Aliment Pharmacol Ther, vol. 23, pp. 71-4, 2006.
J. West, Card, T. R., Aithal, G. P., and Fleming, K. M., “Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study”, Aliment Pharmacol Ther, vol. 45, pp. 983-990, 2017.
R. G. Armstrong, West, J., and Card, T. R., “Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study”, Am J Gastroenterol, vol. 105, pp. 1604-9, 2010.
K. M. Fleming, Aithal, G. P., Card, T. R., and West, J., “The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study”, Aliment Pharmacol Ther, vol. 32, pp. 1343-50, 2010.
P
F. Othman, Card, T. R., and Crooks, C. J., “Proton pump inhibitor prescribing patterns in the UK: a primary care database study”, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1079-87, 2016.
F. K. Varyani, West, J., and Card, T. R., “Primary biliary cirrhosis does not increase the risk of UTIs following diagnosis compared to other chronic liver diseases?”, Liver Int, vol. 33, pp. 384-8, 2013.
T. P. C. Chu, Moran, G. W., and Card, T. R., “The Pattern of Underlying Cause of Death in Patients with Inflammatory Bowel Disease in England: A Record Linkage Study”, J Crohns Colitis, vol. 11, pp. 578-585, 2017.
M
J. West, Logan, R. F., Smith, C. J., Hubbard, R. B., and Card, T. R., “Malignancy and mortality in people with coeliac disease: population based cohort study”, Bmj, vol. 329, pp. 716-9, 2004.
I
T. R. Card, Solaymani-Dodaran, M., Hubbard, R., Logan, R. F., and West, J., “Is an internal comparison better than using national data when estimating mortality in longitudinal studies?”, J Epidemiol Community Health, vol. 60, pp. 819-21, 2006.
H. Jackson, Solaymani-Dodaran, M., Card, T. R., Aithal, G. P., Logan, R., and West, J., “Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study”, Hepatology, vol. 46, pp. 1131-7, 2007.
F. K. Varyani, West, J., and Card, T. R., “An increased risk of urinary tract infection precedes development of primary biliary cirrhosis”, BMC Gastroenterol, vol. 11, p. 95, 2011.
A. J. Walker, Card, T. R., West, J., Crooks, C., and Grainge, M. J., “Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases”, Eur J Cancer, vol. 49, pp. 1404-13, 2013.
S. M. Langan, Groves, R. W., Card, T. R., and Gulliford, M. C., “Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study”, J Invest Dermatol, vol. 132, pp. 2166-70, 2012.
J. West, Fleming, K. M., Tata, L. J., Card, T. R., and Crooks, C. J., “Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study”, Am J Gastroenterol, vol. 109, pp. 757-68, 2014.
T. R. Card, Solaymani-Dodaran, M., and West, J., “Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study”, J Hepatol, vol. 48, pp. 939-44, 2008.
F
M. Solaymani-Dodaran, Card, T. R., Aithal, G. P., and West, J., “Fracture risk in people with primary biliary cirrhosis: a population-based cohort study”, Gastroenterology, vol. 131, pp. 1752-7, 2006.
J. West, Logan, R. F., Card, T. R., Smith, C., and Hubbard, R., “Fracture risk in people with celiac disease: a population-based cohort study”, Gastroenterology, vol. 125, pp. 429-36, 2003.
E
T. R. Card, Siffledeen, J., West, J., and Fleming, K. M., “An excess of prior irritable bowel syndrome diagnoses or treatments in Celiac disease: evidence of diagnostic delay”, Scand J Gastroenterol, vol. 48, pp. 801-7, 2013.
C. J. Crooks, Card, T. R., and West, J., “Excess long-term mortality following non-variceal upper gastrointestinal bleeding: a population-based cohort study”, PLoS Med, vol. 10, p. e1001437, 2013.
C. J. Crooks, West, J., Solaymani-Dodaran, M., and Card, T. R., “The epidemiology of haemochromatosis: a population-based study”, Aliment Pharmacol Ther, vol. 29, pp. 183-92, 2009.
D
C. J. Crooks, Card, T. R., and West, J., “Defining upper gastrointestinal bleeding from linked primary and secondary care data and the effect on occurrence and 28 day mortality”, BMC Health Serv Res, vol. 12, p. 392, 2012.
C
C. J. Crooks, West, J., and Card, T. R., “A comparison of the recording of comorbidity in primary and secondary care by using the Charlson Index to predict short-term and long-term survival in a routine linked data cohort”, BMJ Open, vol. 5, p. e007974, 2015.
C. J. Crooks, West, J., and Card, T. R., “Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding”, Gastroenterology, vol. 144, pp. 1384-93, 1393.e1-2; quiz e18-9, 2013.
F. Othman, Crooks, C. J., and Card, T. R., “Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study”, Bmj, vol. 355, p. i5813, 2016.
M. Solaymani-Dodaran, Card, T. R., and West, J., “Cause-specific mortality of people with Barrett's esophagus compared with the general population: a population-based cohort study”, Gastroenterology, vol. 144, pp. 1375-83, 1383.e1, 2013.
A
A. J. Walker, Grainge, M. J., and Card, T. R., “Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study”, Br J Cancer, vol. 107, pp. 1602-7, 2012.
T. R. Card, Siffledeen, J., and Fleming, K. M., “Are IBD patients more likely to have a prior diagnosis of irritable bowel syndrome? Report of a case-control study in the General Practice Research Database”, United European Gastroenterol J, vol. 2, pp. 505-12, 2014.
A. J. Walker, West, J., Grainge, M. J., and Card, T. R., “Angiotensin converting enzyme inhibitors and hepatocellular carcinoma incidence in the General Practice Research Database”, Cancer Causes Control, vol. 22, pp. 1743-7, 2011.
K. M. Fleming, Aithal, G. P., Card, T. R., and West, J., “All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study”, Liver Int, vol. 32, pp. 79-84, 2012.
B. Numbere, Fleming, K. M., Walker, A., and Card, T. R., “Adrenergic blockers and the risk for common solid cancers: a case-control study”, Eur J Cancer Prev, vol. 26, pp. 86-93, 2017.
[Page last reviewed 6 December 2019]